Delivery Order SPE2DB20D7059-SPE2DB26FGSB5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,121.97 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg tablets in unit dose packages of 20, with an ultimate completion date of August 22, 2025. This is a firm fixed price, non-set-aside contract performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Methylergonovine 0.2 mg tablets (28-count) with a firm fixed price ceiling value of $1,547.44. The contract was competitively awarded with no set-aside designation and is scheduled for ultimate completion on August 22, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylergonovine 0.2 mg/mL in ampule form, with a firm fixed price ceiling value of $2,015.40 and an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Methylergonovine 0.2 mg tablets (12-count packaging) with a ceiling value of $2,410.20. This is a firm fixed-price delivery order with an ultimate completion date of May 2, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Methylergonovine 0.2 mg tablets in unit dose packages of 20, with a ceiling value of $11,136.19. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 15, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among...
- This delivery order, awarded September 11, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of methylergonovine 0.2 mg tablets in quantities of 28 units. The contract is valued at $7,605.24 with a firm fixed price structure and no set-aside designation, indicating competitive award status. Performance will be executed from the awardee's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025....
- The Defense Logistics Agency awarded a $13,917.06 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Methylergonovine 0.2 mg/mL vials. This firm fixed-price contract, with an ultimate completion date of September 25, 2025, was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,734.54 to AmerisourceBergen Drug Corp for methylergonovine 0.2 mg tablets (28-count supply) on September 24, 2025, with an ultimate completion date of September 25, 2025. This firm fixed price delivery order was competitively awarded without any set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,393.28 to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL in vials. This is a firm fixed-price contract with an ultimate completion date of September 29, 2025, and represents a competitively awarded, non-set-aside procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical distribution operations....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for methylergonovine 0.2 mg/mL in a one-milliliter volume on July 9, 2025, with a ceiling value of $4,786.56. This firm fixed-price delivery order, which completes on July 10, 2025, represents a non-competitive set-aside award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Methylergonovine is an ergot alkaloid medication commonly used in obstetric and...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB26FGSB5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Methylergonovine 0.2 mg tablets in quantities of 12 units, with a contract ceiling value of $1,470.46. This firm fixed-price delivery order, which is scheduled for completion by November 5, 2025, will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under AmerisourceBergen's existing contract vehicle with DLA and reflects the company's established role as a critical pharmaceutical distributor for federal medical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026, which serves as the underlying contract vehicle for this delivery order. This prime IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery order for Methylergonovine, a medication used in obstetric care, exemplifies the breadth of pharmaceutical commodities that AmerisourceBergen delivers through its federal contract relationships with the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/4/25 |